IntraBio Inc., a global biopharmaceutical company focused on developing and commercializing therapies for neurological diseases, today announced that the U.S. Food and Drug Administration (FDA) has ...

Tributes are also paid to 'wonderful mum' ...

Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, will announce data from the ongoing Phase 1/2 ...

First participant dosed in the Phase 3 IMPACT DUCHENNE clinical trial, receipt of positive opinion on the Company’s ...

SUNRISE-FA 2 open-label, pivotal trial protocol and SAP for LX2006 submitted to FDA in Q1 2026; Awaiting final FDA feedbackMultiple presentations ...

More beach wheelchairs and all-terrain scooters have been introduced in Lincolnshire to give people better access to beaches ...

First participant dosed in the Phase 3 IMPACT DUCHENNE clinical trial, receipt of positive opinion on the Company's Pediatric Investigation Plan from the European Medicines Agency ...

Clint Trayhern, 54, of Pontypool, will climb Pen Y Fan, the highest peak in South Wales, while carrying a wheelchair and other disability aids on his back. He is taking on the challenge on May 31 in ...

That said, the FDA recently approved a first-of-its-kind oral solution for noise aversion and separation anxiety in dogs, ...

12:39, Tue, Apr 28, 2026 Updated: 12:40, Tue, Apr 28, 2026 The Department for Work and Pensions (DWP) has released a list of medical conditions that have seen people qualify for the weekly £114 ...

On May 6, Sen. Susan Collins, a Republican from Maine, revealed that she’s had a condition called essential tremor throughout ...

The symptoms tend to be persistent, reoccurring and unexplained ...